Acid Anhydride Hydrolases
"Acid Anhydride Hydrolases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. (Enzyme Nomenclature, 1992) EC 3.6.
Below are MeSH descriptors whose meaning is more general than "Acid Anhydride Hydrolases".
Below are MeSH descriptors whose meaning is more specific than "Acid Anhydride Hydrolases".
This graph shows the total number of publications written about "Acid Anhydride Hydrolases" by people in this website by year, and whether "Acid Anhydride Hydrolases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Acid Anhydride Hydrolases" by people in Profiles.
Polyphosphate degradation by Nudt3-Zn2+ mediates oxidative stress response. Cell Rep. 2021 11 16; 37(7):110004.
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities. Clin Cancer Res. 2019 02 15; 25(4):1147-1155.
RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus. Proc Natl Acad Sci U S A. 2018 08 07; 115(32):8197-8202.
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA Oncol. 2017 Sep 01; 3(9):1190-1196.
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncol. 2015 May; 51(5):470-5.
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Res Treat. 2012 Jun; 133(3):865-80.
Impaired replication dynamics at the FRA3B common fragile site. Hum Mol Genet. 2010 Jan 01; 19(1):99-110.
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res. 2009 Jul 15; 69(14):5801-10.
Telomeres: not all breaks are equal. Curr Biol. 2004 Aug 10; 14(15):R613-4.
Early collapse is not an obligate step in protein folding. J Mol Biol. 2004 Apr 23; 338(2):369-82.